| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 93, 771-791, Copyright © 1978 by American Society for Investigative Pathology
REGULAR ARTICLES |
GA Prince, AB Jenson, RL Horswood, E Camargo and RM Chanock
The cotton rat is susceptible to respiratory synctial virus infection in both the upper and lower portions of the respiratory tract. Virus replicates to high titer in the nose and lungs and to relatively low titer in the trachea. Immunofluorescence studies demonstrated viral antigen in the nasal epithelium and the bronchial and bronchiolar epithelium but not in the trachea or the alveolar cells of the lungs. Histopathologic changes included a desquamative, exudative rhinitis of moderate severity and a mild proliferative bronchiolitis. Serum neutralizing antibody developed in all animals by the ninth day after infection, reaching extremely high titer in several instances. Unlike the previously described response of experimentally infected infant ferrets, cotton rats are uniformly susceptible to pulmonary infection throughout life, thereby offering a model for long-term pulmonary studies heretofore not available.
This article has been cited by other articles:
![]() |
L. M. Pletneva, O. Haller, D. D. Porter, G. A. Prince, and J. C. G. Blanco Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats J. Gen. Virol., January 1, 2008; 89(1): 261 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Boukhvalova, G. A. Prince, and J. C. G. Blanco Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity J. Virol., September 1, 2007; 81(17): 9443 - 9450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Williams, S. J. Tollefson, J. E. Johnson, and J. E. Crowe Jr. The Cotton Rat (Sigmodon hispidus) Is a Permissive Small Animal Model of Human Metapneumovirus Infection, Pathogenesis, and Protective Immunity J. Virol., September 1, 2005; 79(17): 10944 - 10951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Hamelin, K. Yim, K. H. Kuhn, R. P. Cragin, M. Boukhvalova, J. C. G. Blanco, G. A. Prince, and G. Boivin Pathogenesis of Human Metapneumovirus Lung Infection in BALB/c Mice and Cotton Rats J. Virol., July 15, 2005; 79(14): 8894 - 8903. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gitiban, J. A. Jurcisek, R. H. Harris, S. E. Mertz, R. K. Durbin, L. O. Bakaletz, and J. E. Durbin Chinchilla and Murine Models of Upper Respiratory Tract Infections with Respiratory Syncytial Virus J. Virol., May 15, 2005; 79(10): 6035 - 6042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Richardson, M. G. Ottolini, L. Pletneva, M. Boukhvalova, S. Zhang, S. N. Vogel, G. A. Prince, and J. C. G. Blanco Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy J. Immunol., April 1, 2005; 174(7): 4356 - 4364. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Alvarez, K. S. Harrod, W.-J. Shieh, S. Zaki, and R. A. Tripp Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies J. Virol., December 15, 2004; 78(24): 14003 - 14011. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cianci, E. V. Genovesi, L. Lamb, I. Medina, Z. Yang, L. Zadjura, H. Yang, C. D'Arienzo, N. Sin, K.-L. Yu, et al. Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2448 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Prince, J. J. Mond, D. D. Porter, K. C. Yim, S. J. Lan, and D. M. Klinman Immunoprotective Activity and Safety of a Respiratory Syncytial Virus Vaccine: Mucosal Delivery of Fusion Glycoprotein with a CpG Oligodeoxynucleotide Adjuvant J. Virol., December 15, 2003; 77(24): 13156 - 13160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bramley, M. A. Khan, H. E. Manson, and R. G. Hegele Development of Respiratory Syncytial Virus "Bronchiolitis" in Guinea Pigs Does Not Reflect an Allergic Predisposition in the Host Chest, August 1, 2003; 124(2): 671 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Curtis, M. G. Ottolini, D. D. Porter, and G. A. Prince Age-Dependent Replication of Respiratory Syncytial Virus in the Cotton Rat Experimental Biology and Medicine, October 1, 2002; 227(9): 799 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Ottolini, S. J. Curtis, D. D. Porter, A. Mathews, J. Y. Richardson, V. G. Hemming, and G. A. Prince Comparison of Corticosteroids for Treatment of Respiratory Syncytial Virus Bronchiolitis and Pneumonia in Cotton Rats Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2299 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Huntley, W. J. Weiss, A. Gazumyan, A. Buklan, B. Feld, W. Hu, T. R. Jones, T. Murphy, A. A. Nikitenko, B. O'Hara, et al. RFI-641, a Potent Respiratory Syncytial Virus Inhibitor Antimicrob. Agents Chemother., March 1, 2002; 46(3): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Prince, S. J. Curtis, K. C. Yim, and D. D. Porter Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine J. Gen. Virol., December 1, 2001; 82(12): 2881 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ponnuraj, A. R. Hayward, A. Raj, H. Wilson, and E. A. F. Simoes Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine J. Gen. Virol., November 1, 2001; 82(11): 2663 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bukreyev, B. R. Murphy, and P. L. Collins Respiratory Syncytial Virus Can Tolerate an Intergenic Sequence of at Least 160 Nucleotides with Little Effect on Transcription or Replication In Vitro and In Vivo J. Virol., December 1, 2000; 74(23): 11017 - 11026. [Abstract] [Full Text] |
||||
![]() |
G. A. Prince, C. Capiau, M. Deschamps, L. Fabry, N. Garçon, D. Gheysen, J.-P. Prieels, G. Thiry, O. Van Opstal, and D. D. Porter Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG Glycoprotein Vaccine in Cotton Rats J. Virol., November 15, 2000; 74(22): 10287 - 10292. [Abstract] [Full Text] |
||||
![]() |
R. J. Langley, G. A. Prince, and H. S. Ginsberg HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus) PNAS, November 24, 1998; 95(24): 14355 - 14360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, S. Sambhara, C. X. Li, M. Ewasyshyn, M. Parrington, J. Caterini, O. James, G. Cates, R.-P. Du, and M. Klein Protection against Respiratory Syncytial Virus Infection by DNA Immunization J. Exp. Med., August 17, 1998; 188(4): 681 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olszewska-Pazdrak, A. Casola, T. Saito, R. Alam, S. E. Crowe, F. Mei, P. L. Ogra, and R. P. Garofalo Cell-Specific Expression of RANTES, MCP-1, and MIP-1alpha by Lower Airway Epithelial Cells and Eosinophils Infected with Respiratory Syncytial Virus J. Virol., June 1, 1998; 72(6): 4756 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Rodriguez, W. C. Gruber, J. R. Groothuis, E. A. F. Simoes, A. J. Rosas, M. Lepow, A. K. , V. Hemming, and the RSV-IGIV Study Group Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children Pediatrics, December 1, 1997; 100(6): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. COLASURDO, V. G. HEMMING, G. A. PRINCE, A. S. GELFAND, J. E. LOADER, and G. L. LARSEN Human Respiratory Syncytial Virus Produces Prolonged Alterations of Neural Control in Airways of Developing Ferrets Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1506 - 1511. [Abstract] [Full Text] |
||||
![]() |
W. J. Rodriguez, W. C. Gruber, R. C. Welliver, J. R. Groothuis, E. A. F. Simoes, H. C. Meissner, V. G. Hemming, C. B. Hall, M. L. Lepow, A. J. Rosas, et al. Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections Pediatrics, March 1, 1997; 99(3): 454 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Groothuis, E. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, et al. Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children N. Engl. J. Med., November 18, 1993; 329(21): 1524 - 1530. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |